Pear Therapeutics Announces Agreement with SoftBank Corp. to Develop a Digital Therapeutic for Sleep/Wake Disorders for the Japanese Market
Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics , today announced an agreement with SoftBank Corp. to develop... | March 21, 2022
Source: marketscreener.com